Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sprifermin adjunct to microfracture in knee cartilage injury
NCT01689337Phase 2Terminated
- Sponsor
- EMD Serono
- Start
- Apr 2013
- Primary completion
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of sprifermin in Cartilage Injury of the Knee, sponsored by EMD Serono. Started Apr 2013; status: terminated.
02
Drugs
sprifermin
03
Conditions
Cartilage Injury of the Knee
Beyond the preview
Go deeper on NCT01689337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01689337.